{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:53:40Z","timestamp":1784091220977,"version":"3.55.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.trre.2023.100817","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T07:02:52Z","timestamp":1702710172000},"page":"100817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunosuppression for older liver transplant recipients"],"prefix":"10.1016","volume":"38","author":[{"given":"Paolo","family":"De Simone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Battistella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quirino","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri","family":"Ducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"D'Arcangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Burra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2023.100817_bb0005","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/tri.13358","article-title":"2018 annual report of the European liver transplant registry (ELTR) \u2013 50-year evolution of liver transplantation","volume":"31","author":"Adam","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2023.100817_bb0010","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ajt.15276","article-title":"OPTN\/SRTR 2017 annual data report: liver","volume":"19","author":"Kim","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2023.100817_bb0015","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/lt.25859","article-title":"Differential impact of extended criteria donors after brain death or circulatory death in adult liver transplantation","volume":"26","author":"Pandya","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2023.100817_bb0020","article-title":"First-in-human liver transplantation from a centenarian deceased donor after brain death","author":"De Simone","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2023.100817_bb0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/SLA.0000000000002305","article-title":"Use of elderly donors in liver transplantation: a pair-matched analysis at a single center","volume":"268","author":"Ghinolfi","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2023.100817_bb0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s40472-020-00283-1","article-title":"The chaning landscapes in DCD liver transplantation","volume":"7","author":"Croome","year":"2020","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.trre.2023.100817_bb0035","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/ajt.16996","article-title":"Outcome of liver transplantation with grafts from brain-dead donors treated with dual hypothermic oxygenated machine perfusion, with particular reference to elderly donors","volume":"22","author":"Patrono","year":"2022","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.trre.2023.100817_bb0040","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/SLA.0000000000006055","article-title":"Routine end-ischemic hypothermic oxygenated perfusion in liver transplantation from donors after brain death: a randomized controlled trial","volume":"278","author":"Grat","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2023.100817_bb0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00595-020-01996-7","article-title":"Liver transplantation in elderly patients: what do we know at the beginning of 2020?","volume":"50","author":"Dolnikov","year":"2020","journal-title":"Surg Today"},{"key":"10.1016\/j.trre.2023.100817_bb0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/lt.23385","article-title":"Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience","volume":"18","author":"Schwartz","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2023.100817_bb0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/archsurg.142.8.775","article-title":"Ghobrial, outcome of liver transplantation in septuagenarians a single-center experience","volume":"142","author":"Lipshutz","year":"2007","journal-title":"Arch Surg"},{"key":"10.1016\/j.trre.2023.100817_bb0060","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0025-6196(11)60667-8","article-title":"Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years","volume":"84","author":"Aduen","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.trre.2023.100817_bb0065","first-page":"1088","article-title":"Is liver transplantation safe and effective in elderly (\u226570 years) recipients?","volume":"16","author":"Wilson","year":"2014","journal-title":"A case-controlled analysis HPB"},{"key":"10.1016\/j.trre.2023.100817_bb0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12072-011-9286-7","article-title":"Age is not a contraindication for orthotopic liver transplantation: a single institution experience with recipients older than 75 years","volume":"6","author":"Taner","year":"2012","journal-title":"Hepatol Int"},{"key":"10.1016\/j.trre.2023.100817_bb0075","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1111\/ajt.14355","article-title":"Living donor liver transplantation for patients older than age 70 years: a single-center experience","volume":"17","author":"Kwon","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2023.100817_bb0080","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2018.12.009","article-title":"Age and liver transplantation","volume":"70","author":"Durand","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.trre.2023.100817_bb0085","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jamasurg.2017.5040","article-title":"Evaluation of early allograft function using the liver graft assessment following transplantation risk score model","volume":"153","author":"Agopian","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.trre.2023.100817_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.4095","article-title":"Development and validation of a comprehensive model to estimate early allograft failure among patients requiring early liver retransplant","volume":"155","author":"Avolio","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.trre.2023.100817_bb0095","article-title":"Cirrhosis-related sarcopenia may not resolve after liver transplantation","volume":"5","author":"Brown","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.trre.2023.100817_bb0100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12871-023-02321-8","article-title":"Factors associated with mechanical ventilation longer than 24 h after liver transplantation in patients at risk for bleeding","volume":"23","author":"Caballero","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.trre.2023.100817_bb0105","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2017.06.009","article-title":"Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3","volume":"67","author":"Artru","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.trre.2023.100817_bb0110","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/TP.0000000000000090","article-title":"Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes","volume":"98","author":"Sharpton","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2023.100817_bb0115","doi-asserted-by":"crossref","first-page":"E188","DOI":"10.1111\/j.1399-0012.2010.01230.x","article-title":"Liver transplantation in patients aged 65 and over: a case-control study","volume":"24","author":"Montalti","year":"2010","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2023.100817_bb0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1399-0012.2007.00749.x","article-title":"Our experience in liver transplantation in patients over 65 yr of age","volume":"22","author":"Bilbao","year":"2008","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2023.100817_bb0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.hpb.2018.07.025","article-title":"Liver transplantation in elderly patients: a systematic review and first meta-analysis","volume":"21","author":"G\u00f3mez Gavara","year":"2019","journal-title":"HPB"},{"key":"10.1016\/j.trre.2023.100817_bb0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bpg.2017.03.001","article-title":"Modification of immunosuppressive therapy as risk factor for complications after liver transplantation","volume":"31","author":"De Simone","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.trre.2023.100817_bb0135","first-page":"930","article-title":"Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian working group","volume":"146","author":"Cillo","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.trre.2023.100817_bb0140","article-title":"ERAS4OLT.org working group","volume":"36","author":"De Martin","year":"2022","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2023.100817_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101485","article-title":"Evaluation of rejection, infection, and malignancy outcomes in elderly liver transplant recipients receiving a similar level of immunosuppression compared to a younger group","volume":"69","author":"Almalki","year":"2021","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trre.2023.100817_bb0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.trre.2013.03.001","article-title":"Immunosenescence and organ transplantation","volume":"27","author":"Heinbokel","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.trre.2023.100817_bb0155","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.humimm.2018.06.006","article-title":"Increased T cell immunosenescence and accelerated maturation phenotypes in older kidney transplant recipients","volume":"79","author":"Schaenman","year":"2018","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2023.100817_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40472-019-0222-4","article-title":"Frailty and outcomes after liver transplantation","volume":"6","author":"Tapper","year":"2019","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.trre.2023.100817_bb0165","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.4049\/jimmunol.114.6.1659","article-title":"Thymic involution: effect on T cell differentiation","volume":"114","author":"Hirokawa","year":"1975","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2023.100817_bb0170","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.4049\/jimmunol.174.11.7446","article-title":"The influence of age on T cell generation and TCR diversity","volume":"174","author":"Naylor","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2023.100817_bb0175","doi-asserted-by":"crossref","first-page":"12182","DOI":"10.1128\/JVI.75.24.12182-12187.2001","article-title":"Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals","volume":"75","author":"Goronzy","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.trre.2023.100817_bb0180","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.4049\/jimmunol.168.11.5893","article-title":"Lack of antibody production following immunization in old age: association with CD8(+)CD28(\u2212) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines","volume":"168","author":"Saurwein-Teissl","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2023.100817_bb0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","article-title":"Immunosenescence: a key player in cancer development","volume":"13","author":"Lian","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.trre.2023.100817_bb0190","author":"OPTN\/SRTR 2017 Annual Data Report: Liver"},{"key":"10.1016\/j.trre.2023.100817_bb0195","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.humimm.2018.06.006","article-title":"Increased T cell immunosenescence and accelerated maturation phenotypes in older kidney transplant recipients","volume":"79","author":"Schaenman","year":"2018","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2023.100817_bb0200","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev-cellbio-011620-034148","article-title":"B Cell Immunosenescence","volume":"36","author":"Frasca","year":"2020","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.trre.2023.100817_bb0205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/tri.12249","article-title":"Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation","volume":"27","author":"Longuet","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2023.100817_bb0210","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2010.03210.x","article-title":"Immune reconstitution following rabbit antithymocyte globulin","volume":"10","author":"Gurkan","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2023.100817_bb0215","doi-asserted-by":"crossref","first-page":"478S","DOI":"10.1093\/ajcn\/66.2.478S","article-title":"Nutrition and immunity in the elderly: modification of immune responses with nutritional treatments","volume":"66","author":"Lesourd","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.trre.2023.100817_bb0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/jlts.2002.29350","article-title":"De novo tumors after liver transplantation: a single-institution experience","volume":"8","author":"Sanchez","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2023.100817_bb0225","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.phrs.2018.02.031","article-title":"Personalized immunosuppression in elderly renal transplant recipients","volume":"130","author":"Peeters","year":"2018","journal-title":"Pharm Res"},{"key":"10.1016\/j.trre.2023.100817_bb0230","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/MOT.0000000000000220","article-title":"Understanding alterations in drug handling with aging: a focus on the pharmacokinetics of maintenance immunosuppressants in the elderly","volume":"20","author":"Gabardi","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.trre.2023.100817_bb0235","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.tp.0000275423.69689.dc","article-title":"Immunosuppression of the elderly kidney transplant recipient","volume":"84","author":"Danovitch","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2023.100817_bb0240","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11255-008-9489-6","article-title":"Renal transplantation in the elderly","volume":"41","author":"Saxena","year":"2009","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.trre.2023.100817_bb0245","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1016\/S0041-1345(01)02326-0","article-title":"Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index","volume":"33","author":"Hortal","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2023.100817_bb0250","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.56.2.4","article-title":"Aging biology and geriatric clinical pharmacology","volume":"56","author":"McLean","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.trre.2023.100817_bb0255","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0009-9120(94)90032-9","article-title":"Effect of age and disease on two drug binding proteins: albumin and alpha-1- acid glycoprotein","volume":"27","author":"Woo","year":"1994","journal-title":"Clin Biochem"},{"key":"10.1016\/j.trre.2023.100817_bb0260","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/clinchem\/41.7.1011","article-title":"Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics","volume":"41","author":"Nowak","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.trre.2023.100817_bb0265","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000052829","article-title":"The aging liver: structural and functional changes and their consequences for drug treatment in old age","volume":"48","author":"Zeeh","year":"2002","journal-title":"Gerontology"},{"key":"10.1016\/j.trre.2023.100817_bb0270","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/00912709922008353","article-title":"The effect of renal insufficiency on mycophenolic acid protein binding","volume":"39","author":"Kaplan","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.trre.2023.100817_bb0275","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/SMJ.0b013e31825fed90","article-title":"Pharmacotherapy considerations in elderly adults","volume":"105","author":"Wooten","year":"2012","journal-title":"South Med J"},{"key":"10.1016\/j.trre.2023.100817_bb0280","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0009-9236(97)90166-1","article-title":"Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions","volume":"61","author":"Sotaniemi","year":"1997","journal-title":"Clin Pharmacol Therap"},{"key":"10.1016\/j.trre.2023.100817_bb0285","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1124\/jpet.103.061077","article-title":"Age-related differences in CYP3A expression and activity in the rat liver, intestine, and kidney","volume":"309","author":"Warrington","year":"2004","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.trre.2023.100817_bb0290","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0006-2952(95)00192-3","article-title":"Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver","volume":"50","author":"George","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.trre.2023.100817_bb0295","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.trre.2023.100817_bb0300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/clpt.2011.104","article-title":"Implications of obesity for drug therapy: limitations and challenges","volume":"90","author":"Jain","year":"2011","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.trre.2023.100817_bb0305","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1476-5381.2011.01270.x","article-title":"Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus","volume":"163","author":"Dostalek","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trre.2023.100817_bb0310","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3389\/fendo.2023.1143835","article-title":"Age-related modifications in CYP-dependent drug metabolism: role of stress","volume":"14","author":"Konstandi","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.trre.2023.100817_bb0315","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/092986707780090981","article-title":"The effect of ageing on cytochrome p450 enzymes: consequences for drug biotransformation in the elderly","author":"Wauthier","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.trre.2023.100817_bb0320","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neubiorev.2014.05.011","article-title":"Consequences of psychophysiological stress on cytochrome P450-catalyzed drug metabolism","volume":"45","author":"Konstandi","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.trre.2023.100817_bb0325","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.biochem.71.102301.093055","article-title":"Mammalian ABC transporters in health and disease","volume":"71","author":"Borst","year":"2002","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.trre.2023.100817_bb0330","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00003088-200140030-00002","article-title":"The gut as a barrier to drug absorption. Combined role of cytochrome P450 and P-glycoprotein","volume":"40","author":"Zhang","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.trre.2023.100817_bb0335","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/00912709922011755","article-title":"P-glycoprotein and drug therapy in organ transplantation","volume":"39","author":"Lo","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.trre.2023.100817_bb0340","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1359-6446(01)01892-X","article-title":"Eichelbaum M (2001) pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy","volume":"6","author":"Brinkmann","year":"2001","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.trre.2023.100817_bb0345","first-page":"97","article-title":"P-glycoprotein function in the elderly","volume":"60","author":"Brenner","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.trre.2023.100817_bb0350","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1111\/j.1600-6143.2012.04232.x","article-title":"Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughs","volume":"12","author":"Jacobson","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2023.100817_bb0355","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/TP.0000000000001369","article-title":"Longitudinal pharmacokinetics of tacrolimus in elderly compared with younger recipients in the first 6 months after renal transplantation","volume":"101","author":"David-Neto","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2023.100817_bb0360","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/TP.0b013e31818aa4b6","article-title":"Reduced elimination of cyclosporine a in elderly (>65 years) kidney transplant recipients","volume":"86","author":"Falck","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2023.100817_bb0365","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/bcp.13154","article-title":"The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients","volume":"83","author":"Tang","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.trre.2023.100817_bb0370","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.2005.02398.x","article-title":"Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling","volume":"60","author":"Cremers","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.trre.2023.100817_bb0375","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/1060028016647974","article-title":"Antithymocyte globulin induction therapy in liver transplant: old drug, new uses","volume":"50","author":"Petite","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.trre.2023.100817_bb0380","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2165\/00003495-200969110-00007","article-title":"Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection","volume":"69","author":"Deeks","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.trre.2023.100817_bb0385","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1083-8791(03)00127-7","article-title":"Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation","volume":"9","author":"Waller","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.trre.2023.100817_bb0390","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2165\/00003495-200363240-00009","article-title":"Basiliximab: a review of its use as induction therapy in renal transplantation","volume":"63","author":"Chapman","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.trre.2023.100817_bb0395","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mcp.2001.112969","article-title":"Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine","volume":"69","author":"Kovarik","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.trre.2023.100817_bb0400","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1067\/mcp.2001.118022","article-title":"Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications","volume":"70","author":"Kovarik","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.trre.2023.100817_bb0405","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1053-2498(00)00232-1","article-title":"RAD in stable lung and heart\/lung transplant recopients: safety, tolerability, pharmacokinetics, and impact on cystic fibrosis","volume":"20","author":"Kovarik","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2023.100817_bb0410","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00003088-200443020-00002","article-title":"Clinical pharmacokinetics of everolimus","volume":"43","author":"Kirchner","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.trre.2023.100817_bb0415","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1097\/TP.0000000000001549","article-title":"Longitudinal pharmacokinetics of everolimus when combined with low-level of tacrolimus in elderly renal transplant recipients","volume":"101","author":"David-Neto","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2023.100817_bb0420","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40262-012-0007-8","article-title":"Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation","volume":"51","author":"Bergmann","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.trre.2023.100817_bb0425","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/clpt.1988.43","article-title":"Kinetics of prednisolone and endogenous cortisol suppression in the elderly","volume":"43","author":"Stuck","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.trre.2023.100817_bb0430","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/ajt.12762","article-title":"Frailty predicts waitlist mortality in liver transplant candidates","volume":"14","author":"Lai","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2023.100817_bb0435","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cger.2010.08.002","article-title":"Inflammation and immune system alterations in frailty","volume":"27","author":"Yao","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.trre.2023.100817_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102082","article-title":"Recent developments in frailty identification, managment, risk factors and prevention: a narrative review of leading journals in geriatrics and gerontology","volume":"91","author":"Dent","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.trre.2023.100817_bb0445","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11912-021-01097-9","article-title":"Determination of biological age: geriatric assessment vs biological biomarkers","volume":"23","author":"Diebel","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.trre.2023.100817_bb0450","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1172\/JCI66370","article-title":"Telomeres and age-related disease: how telomere biology informs clinical paradigms","volume":"123","author":"Armanios","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trre.2023.100817_bb0455","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","article-title":"DNA methylation-based biomarkers and the epigenetic clock theory of ageing","volume":"19","author":"Horvath","year":"2018","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.trre.2023.100817_bb0460","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/genes3030344","article-title":"The human transcriptome: an unfinished story","volume":"3","author":"Pertea","year":"2012","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.trre.2023.100817_bb0465","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/gerona\/glu121","article-title":"Circulating proteomic signatures of chronological age","volume":"70","author":"Menni","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.trre.2023.100817_bb0470","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/4551054a","article-title":"Systems biology: metabonomics","volume":"455","author":"Nicholson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.trre.2023.100817_bb0475","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2174\/18715206113139990322","article-title":"Assessment of nutritional status in cancer\u2013the relationship between body composition and pharmacokinetics","volume":"13","author":"Prado","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.trre.2023.100817_bb0480","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/138920011794520035","article-title":"Does hepatic steatosis affect drug metabolizing enzymes in the liver?","volume":"12","author":"Buechler","year":"2011","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.trre.2023.100817_bb0485","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0165-6147(83)90411-X","article-title":"Drug metabolism and pharmacokinetics in malnutrition","volume":"4","author":"Krishnaswany","year":"1983","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.trre.2023.100817_bb0490","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s40266-022-00952-z","article-title":"Frailty and potentially inappropriate prescribing in older people with polypharmacy: a bi-directional relationship?","volume":"39","author":"Randles","year":"2022","journal-title":"Drugs Aging"},{"key":"10.1016\/j.trre.2023.100817_bb0495","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/PPA.S29549","article-title":"Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions","volume":"7","author":"Hugtenburg","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.trre.2023.100817_bb0500","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/lt.25669","article-title":"Liver frailty is associated with increased rates of acute cellular rejection within 3 months after liver transplantation","volume":"26","author":"Fozouni","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2023.100817_bb0505","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/lt.25690","article-title":"Frailty is associated with increased rates of acute cellular rejection within 3 months after liver transplantation","volume":"26","author":"Brown","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2023.100817_bb0510","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s40472-021-00321-6","article-title":"Immunosuppression considerations for older kidney transplant recipients","volume":"8","author":"Cheungpasitporn","year":"2021","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.trre.2023.100817_bb0515","article-title":"Long-term management of elderly patients taking immunosuppressive medications","volume":"49","author":"Ivulich","year":"2020","journal-title":"AJGP"},{"key":"10.1016\/j.trre.2023.100817_bb0520","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev-psych-010419-050754","article-title":"Family caregiving for older adults","volume":"71","author":"Schulz","year":"2020","journal-title":"Annu Rev Psychol"},{"key":"10.1016\/j.trre.2023.100817_bb0525","article-title":"Impact of pre-transplant diabetes on outcomes after liver transplantation: and updated meta-analysis with systematic review","author":"Tang","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2023.100817_bb0530","doi-asserted-by":"crossref","first-page":"1229990","DOI":"10.3389\/fneur.2023.1229990","article-title":"The influence of delirium on mortality and length of ICU stay and analysis of risk factors for delirium after liver transplantation","volume":"14","author":"Ma","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.trre.2023.100817_bb0535","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.transproceed.2012.01.041","article-title":"The risk factors to predict acute rejection in liver transplantation","volume":"44","author":"Wang","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2023.100817_bb0540","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/HEP.0000000000000363","article-title":"Acute rejection after liver transplantation with machine perfusion versus cold storage: a systematic review and meta-analysis","volume":"78","author":"Maspero","year":"2023","journal-title":"Hepatology"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X2300071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X2300071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T16:08:02Z","timestamp":1760630882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X2300071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0955470X2300071X"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2023.100817","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppression for older liver transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2023.100817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100817"}}